Metabolism News and Research

Latest Metabolism News and Research

Prolonged sitting time, reduced physical activity contribute to non-alcoholic fatty liver disease

Prolonged sitting time as well as reduced physical activity contribute to the prevalence of non-alcoholic fatty liver disease (NAFLD) in a study of middle-aged Koreans.

15 Sep 2015

Virginia Tech scientists discover new treatments to target antibiotic-resistant bacteria

Virginia Tech researchers have discovered a new group of antibiotics that may provide relief to some of the more than 2 million people in the United States affected by antibiotic resistance.

14 Sep 2015

Novel long non-coding RNA has potential to stymie growth of tumor cells in colon cancer

Genetics researchers from Case Western Reserve School of Medicine have identified a novel long non-coding RNA (lncRNA), dubbed DACOR1, that has the potential to stymie the growth of tumor cells in the second-most deadly form of cancer in the U.S. — colorectal cancer.

14 Sep 2015

Diabetes drug 'suffocates' pancreatic cancer stem cells, new study finds

A new study shows that pancreatic cancer stem cells (PancSCs) are virtually addicted to oxygen-based metabolism, and could be "suffocated" with a drug already used to treat diabetes.

14 Sep 2015

Male, female researchers at Johns Hopkins Department of Medicine get similar rates of research funding

Though national data suggest that women researchers are less likely to obtain independent research funding than men, a study published in the Journal of Women’s Health found that male and female researchers at the Johns Hopkins University School of Medicine are funded at nearly the same rate.

14 Sep 2015

Weaker physical fitness, higher body fat content linked to arterial stiffness in children

Arterial wall stiffness and reduced arterial dilation are the first signs of cardiovascular diseases that can be measured. The Physical Activity and Nutrition in Children Study (PANIC) carried out in the Institute of Biomedicine at the University of Eastern Finland shows that low levels of physical activity, weaker physical fitness and higher body fat content are linked to arterial stiffness already in 6-8 year-old children.

14 Sep 2015

FGF21 compound in breast milk plays key role in neonatal nutrient absorption, intestinal function

A compound found in breast milk, named fibroblast growth factor 21 (FGF21), plays a key role in neonatal nutrient absorption and intestinal function. FGF21 also contributes to improve newborn growth and metabolic profile.

11 Sep 2015

EMBL researchers use mass spectrometry data to analyze effects of cancer drugs

Researchers at EMBL's European Bioinformatics Institute (EMBL-EBI) have developed a new method for studying the targets and effects of cancer drugs using data from discovery mass spectrometry (MS) experiments.

11 Sep 2015

Allergan settles patent litigation with Amneal related to NAMENDA XR extended release capsules

Allergan plc, today announced that its subsidiaries Forest Laboratories, LLC and Forest Laboratories Holdings, Ltd., along with Adamas Pharmaceuticals, Inc., have entered into a settlement agreement with Amneal Pharmaceuticals LLC and related companies and subsidiaries.

10 Sep 2015

New research enables ‘tailored’ diet advice based on personal gut microbiome

New research enables "tailored" diet advice - based on our personal gut microbiome - for persons who want to lose weight and reduce the risk of disease.

10 Sep 2015

Researchers take new line of approach to combat Alzheimer's disease

Today, more than 5.1 million Americans live with Alzheimer's disease, a devastating type of dementia that plagues memory and thinking. That number is expected to triple in the coming decades. Moreover, according to a 2012 survey, Americans fear Alzheimer's more than any other disease.

10 Sep 2015

Dietary uptake of microRNAs certainly insufficient to affect physiological functions, reveal ETH biologists

The scientific world was astonished when, in 2011, Chinese researchers claimed to have found evidence suggesting that minute fragments of plant genetic material - so-called microRNA molecules - of rice ingested from food could play a role in regulating physiological processes in the human body. If this is indeed true, it might even be possible to deliberately modify human physiological functions via this route, for instance by incorporating microRNAs into novel functional foods.

9 Sep 2015

Helsinn, BIAL sign exclusive distribution and licence agreement for Anamorelin

Helsinn, the Swiss Group focused on building quality cancer care, and BIAL - Portela & Ca. S.A., one of the largest Iberian pharmaceutical companies, today announce that they have entered into an agreement for the exclusive distribution and licence rights to Anamorelin in Spain, Portugal, Angola and Mozambique.

8 Sep 2015

Inhibiting key protein involved in glucose production may help in treating type 2 diabetes

Some treatments for type 2 diabetes make the body more sensitive to insulin, the hormone that lowers blood sugar. But new research at Washington University School of Medicine in St. Louis suggests a different strategy: slowing the production of glucose in the liver.

4 Sep 2015

Gut bacteria play major role in diabetes, obesity depending on host’s genetic makeup

The trillions of bacteria in your digestive system play a major role in your metabolism, and they're linked to your risks of type 2 diabetes, obesity and the related conditions that make up "metabolic syndrome," which has become a global health epidemic.

4 Sep 2015

Prenatal exposure to historical Ukraine Famine increases risk for Type 2 diabetes

Men and women exposed in early gestation to the man-made Ukrainian Famine of 1932-33 in regions with extreme food shortages were 1.5 times more likely to be diagnosed with Type 2 diabetes in adulthood.

4 Sep 2015

Mitochondrial Pyruvate Carrier could potentially be a new drug target to treat diabetes

High blood sugar is a defining characteristic of Type 2 diabetes and the cause of many of the condition's complications, including kidney failure, heart disease, and blindness. Most diabetes medications aim to maintain normal blood sugar (glucose) levels and prevent high blood sugar by controlling insulin.

3 Sep 2015

Valerion announces positive results from non-clinical pilot study of VAL-1221 for treatment of Pompe disease

Valerion Therapeutics, LLC yesterday announced positive results from a non-clinical "proof of concept" pilot study for a novel humanized antibody and acid alpha glucosidase (GAA) fusion candidate for the treatment of Pompe disease.

3 Sep 2015

Inhalation exposure to PM2.5 pollution triggers liver fibrosis

A research team led by Kezhong Zhang, Ph.D., at the Wayne State University School of Medicine's Center for Molecular Medicine and Genetics, has discovered that exposure to air pollution has a direct adverse health effect on the liver and causes liver fibrosis, an illness associated with metabolic disease and liver cancer.

3 Sep 2015

Huntington’s disease prevention breakthrough? An interview with Professor Lesley Jones

Huntington’s disease is an inherited disease which, whilst quite rare, is one of the more common inherited neurodegenerative diseases. About 1 in 6,000 people in the UK are at risk and what’s horrible about this disease is that if one of your parents has it, then you have a fifty-fifty chance of inheriting it.

2 Sep 2015

Metabolism News and Research

Latest Metabolism News and Research

Prolonged sitting time, reduced physical activity contribute to non-alcoholic fatty liver disease

Virginia Tech scientists discover new treatments to target antibiotic-resistant bacteria

Novel long non-coding RNA has potential to stymie growth of tumor cells in colon cancer

Diabetes drug 'suffocates' pancreatic cancer stem cells, new study finds

Male, female researchers at Johns Hopkins Department of Medicine get similar rates of research funding

Weaker physical fitness, higher body fat content linked to arterial stiffness in children

FGF21 compound in breast milk plays key role in neonatal nutrient absorption, intestinal function

EMBL researchers use mass spectrometry data to analyze effects of cancer drugs

Allergan settles patent litigation with Amneal related to NAMENDA XR extended release capsules

New research enables ‘tailored’ diet advice based on personal gut microbiome

Researchers take new line of approach to combat Alzheimer's disease

Dietary uptake of microRNAs certainly insufficient to affect physiological functions, reveal ETH biologists

Helsinn, BIAL sign exclusive distribution and licence agreement for Anamorelin

Inhibiting key protein involved in glucose production may help in treating type 2 diabetes

Gut bacteria play major role in diabetes, obesity depending on host’s genetic makeup

Prenatal exposure to historical Ukraine Famine increases risk for Type 2 diabetes

Mitochondrial Pyruvate Carrier could potentially be a new drug target to treat diabetes

Valerion announces positive results from non-clinical pilot study of VAL-1221 for treatment of Pompe disease

Inhalation exposure to PM2.5 pollution triggers liver fibrosis

Huntington’s disease prevention breakthrough? An interview with Professor Lesley Jones

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications